Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 22'nd Aug 2025
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
My 5 Favorite Stocks to Buy Right Now
04:35am, Friday, 22'nd Aug 2025
Is your portfolio getting thinned out by all the profit-taking that tends to materialize when the market reaches record highs? That's OK.
Low Volatility Calls For This Breakout Trade On Pfizer Stock
11:15am, Thursday, 21'st Aug 2025
Pfizer stock currently trades at very low volatility. That could mean it's ripe for a breakout trade, like a long strangle.
Pfizer: Shares Are Cheap, But They Could Get Even Cheaper Next Year
09:55am, Thursday, 21'st Aug 2025
I remain bearish on Pfizer due to pricing pressures from IRA/340B and a looming 2026 patent cliff, despite Q2 2025 earnings beat. Cost-cutting measures have lifted EPS above expectations and could del
Pfizer: Stagnation Is An Investment Opportunity
03:47am, Thursday, 21'st Aug 2025
Pfizer offers an attractive near-7% dividend yield, appealing for income-focused investors. Despite recent stagnation, Pfizer has consistently maintained its dividend payout and remains undervalued. T
Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union
07:00am, Wednesday, 20'th Aug 2025
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immuno
My Top Dividend-Paying, Deep-Value Stock to Buy in August
04:51am, Wednesday, 20'th Aug 2025
What's better than a stock that pays great dividends? How about one that's also a bargain?
Pfizer Oncology Drugs Drive Sales in Q2: Will the Trend Continue?
10:10am, Tuesday, 19'th Aug 2025
Pfizer's oncology portfolio, boosted by Seagen and strong drug sales, fuels Q2 growth and positions the company for future cancer treatment gains.
Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True?
04:50am, Tuesday, 19'th Aug 2025
Finding a high-yielding stock that is safe to hang on to can be a rarity. When yields get high (e.g.
These 3 Dividend Stocks Have Yields Above 5%, Plus They Raise Their Payouts Every Year
05:23am, Monday, 18'th Aug 2025
If you're looking to boost your passive income stream with dividend-paying stocks, there's a tough dilemma that we all face. Stocks that offer high yields generally do so because their dividend payout
2 Top Dividend Stocks to Buy on the Dip
09:07am, Saturday, 16'th Aug 2025
Dividend stocks are a great investment choice for many reasons. Buying on the dip is even better, provided, of course, they have the means to bounce back.
Pfizer: This Is What Bulls Waited For
04:19am, Saturday, 16'th Aug 2025
Pfizer crushed Q2 estimates with $14.7B revenue and $0.78 EPS, signaling a powerful turnaround driven by broad-based growth and operational excellence. A successful cost realignment program drove the
Pfizer experimental sickle cell drug fails phase 3 trial
11:49am, Friday, 15'th Aug 2025
CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest news on drugmaker Pfizer.
Pfizer's sickle cell drug fails main goal in late-stage trial
11:01am, Friday, 15'th Aug 2025
Pfizer said on Friday that its experimental sickle cell disease drug failed to meet the main goal in a late stage trial in patients 16 years of age and older.
3 Long-Term Dividend Buys You Can Get for Under $50
08:35am, Friday, 15'th Aug 2025
Despite ongoing concerns about overvalued stocks, many value investors sleep well at night. That's because the key to long-term value investing is total return, which includes a healthy, growing divid
